FCS Press Releases

Florida Cancer Specialists & Research Institute (FCS) is seeking to reduce deaths and suffering from hereditary cancers with the launch of a cancer genetics program across its statewide practice. The use of a powerful and proven technology tool developed by Chicago-based software and data analytics company, CancerIQ, and the addition of a specially-trained genetic professional will help identify patients whose cancer is linked to genetics and those at increased likelihood of developing cancer.

Florida Cancer Specialists & Research Institute (FCS), is pleased to announce that radiation oncologist, Kunal Saigal, MD will lead the new Sarasota Memorial Radiation Oncology Center, which opens August 3, 2020. The 18,000 square foot outpatient radiation center completes the first phase of the planned community Cancer Institute by Sarasota Memorial Health Care System (SMH), boasting two Varian TrueBeam linear accelerators, which are considered the gold standard for radiation oncology.

Florida Cancer Specialists & Research Institute (FCS), recently cut the ribbon on a new state-of-the-art facility at 1396 Whisper Circle, Sebring, FL to provide comprehensive treatments and a variety of services to adults with cancer and other diseases. The new location replaces the existing FCS clinic at 4420 Sun-N-Lake Blvd. in Sebring.

Florida Cancer Specialists & Research Institute (“FCS” or the “Company”), announced that FCS Chief Financial Officer Nathan H. Walcker has been named Chief Executive Officer, effective August 1, 2020. Walcker will succeed current Chief Executive Officer Brad Prechtl, MBA, who will retire from FCS, effective July 30, 2020, but continue to serve as a consultant through April 2021.

Lucio Gordan, MD, will lead an educational session at the Community Oncology Advocacy Summit Scheduled for July 15, 2020.

Florida Cancer Specialists & Research Institute (FCS) recently celebrated the start of construction of its new Trinity Cancer Center. When complete in early 2021, the 37,000 square foot facility will include radiation oncology and next-generation PET/CT imaging technology along with 27 exam rooms and 52 chairs for chemotherapy and other infusions. Patients will also have access to participate in cutting-edge clinical trial research.

Florida Cancer Specialists & Research Institute (FCS) is pleased to announce the opening of a new office location in Middleburg, Florida on June 1, 2020. FCS currently has a clinic location in Fleming Island, making the Middleburg site its second location in the greater Jacksonville area.

Melody Chang, RPh, MBA, BCOP, director of pharmacy operations for Florida Cancer Specialists & Research Institute (FCS), has published an article concerning the ongoing controversy surrounding the treatment of cancer patients with medical marijuana or other cannabinoid-derived products.

Florida Cancer Specialists & Research Institute (FCS) physicians are the co-authors of 20 research studies that will be presented at the American Society of Clinical Oncology (ASCO®) ASCO20 Virtual Scientific Program being held May 29 – 31, 2020.

Despite the many challenges of the current health care crisis, patients of  Florida Cancer Specialists & Research Institute (FCS) report high satisfaction with the oncology provider’s response and efforts to provide care safely, and with little or no disruption.

Advanced radiation therapy options lead to faster and shorter rounds of radiation therapy for patients with certain types of cancer.

Florida Cancer Specialists & Research Institute (FCS) recently launched telehealth services across all FCS sites statewide, allowing patients continued and convenient access to care, while mitigating the impact and spread of COVID-19. This virtual care solution plays a vital role in response to the pandemic crisis, maintaining patient access to care directly from home. FCS was among the first cancer care groups in Florida to launch telehealth resources to cancer patients during the pandemic.

Today we cut the ribbon to celebrate our new FCS Lake Mary Cancer Center and Sarah Cannon Research Institute Drug Development Unit at FCS!

Florida Cancer Specialists & Research Institute (FCS) will expand access to comprehensive cancer treatment and opportunities for patients to participate in cutting-edge cancer research with the opening of its FCS Cancer Center and Sarah Cannon Research Institute Drug Development Unit in Lake Mary later this month.

Florida Cancer Specialists & Research Institute (FCS) has met the accreditation standards required by the Better Business Bureau for membership and has received the organization’s A+ rating.

Florida Cancer Specialists & Research Institute (FCS) and Cedar, a patient engagement and payment technology platform, today announced that they are partnering to modernize the on-line payment experience for FCS patients.